Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Kimia Biosciences Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Option Chain
Analyzes market sentiment, predicts Kimia Biosciences Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Kimia Biosciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Kimia Biosciences - ANNOUNCEMENT UNDER REGULATION 30(LODR) REGARDING THE CLARIFICAION -PRICE MOVEMENT
-
Kimia Biosciences - Clarification sought from Kimia Biosciences Ltd
-
Kimia Biosciences - Intimation Of Newspaper Advertisement Of Extraordinary General Meeting And E-Voting Information.\r\n
-
Kimia Biosciences - INTIMATION FOR THE APPOINTMENT OF INTERNAL AUDITOR FOR THE FINANCIAL YEAR 2025-2026
-
Kimia Biosciences - INTIMATION FOR THE APPOINTMENT OF SECRETARIAL AUDITOR FOR THE FINANCIAL YEAR 2024-2025
-
Kimia Biosciences - INTIMATION FOR THE APPOINTMENT OF ADDITIONAL DIRECTOR ,REGULARISATION WILL BE DONE IN ENSUING EGM SCHEDUL
-
Kimia Biosciences - INTIMATION FOR THE APPOINTMENT OF COST AUDITOR
-
Kimia Biosciences - Disclosure under Regulation 30A of LODR
-
Kimia Biosciences - Disclosure under Regulation 30A of LODR
-
Kimia Biosciences - Disclosure under Regulation 30A of LODR
-
Kimia Biosciences - Disclosure under Regulation 30A of LODR
-
Kimia Biosciences - Board Meeting Outcome for Board Meeting Outcome As Per Regulation 30SEBI(LODR)
-
Kimia Biosciences - Reg. 34 (1) Annual Report.
-
Kimia Biosciences - INTIMATION OF BOARD MEETING UNDER REGULATION 29(1)(D) OF SEBI (LODR) REGULATIONS,2015
-
Kimia Biosciences - Revised Board Meeting Outcome Held On 26 May,2025 Document For The Quarter And Financial Year Ended On 31
-
Kimia Biosciences - Non-Applicability Of Regulation 24A Of SEBI(Listing Obligation And Disclosure ),Regulations,2015
-
Kimia Biosciences - Financial Results Ended On 31 March 2025
-
Kimia Biosciences - Newspaper Publication Of Financial Results As Per Regulation 30 Of Securities Exchange Board Of India,201
-
Kimia Biosciences Q4 net profit up 10.56% at Rs 1.99 cr
-
Kimia Biosciences - Integrated Filing (Financial)
-
Kimia Biosciences - Board Meeting Outcome for Outcome Of The Financials In The Board Meeting
-
Kimia Biosciences - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
-
Kimia Biosciences - Board Meeting Intimation for Approval Of Audited Financials For The Quarter And Financial Year Ended On 3
-
Kimia Biosciences - Board Meeting Outcome for Outcome Of Board Meeting Held On 05Th May 2025 Pursuant To Regulation 30 Of SEB
-
Kimia Biosciences - Board Meeting Intimation for Payment To Redeemable Preference Shares
-
Kimia Biosciences - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
-
Kimia Biosciences - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
-
Kimia Biosciences - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
-
Kimia Biosciences - Board Meeting Outcome for Outcome Of Board Meeting 23.04.2025
Key fundamentals
Evaluate the intrinsic value of Kimia Biosciences Ltd stock
| Name | March-24 | March-23 | March-22 | March-21 | March-20 |
|---|---|---|---|---|---|
| Assets | 49.5394 | 63.7096 | 55.5039 | 59.9092 | 44.0018 |
| Liabilities | 49.5394 | 63.7096 | 55.5039 | 59.9092 | 44.0018 |
| Equity | 4.7313 | 4.7313 | 4.7313 | 4.7313 | 4.6354 |
| Gross Profit | -0.4834 | -4.9759 | 0.6314 | 8.3787 | 4.4512 |
| Net Profit | -5.3087 | -9.3522 | -3.703 | 5.1043 | 1.381 |
| Cash From Operating Activities | 14.5348 | -6.77 | 0 | 5.967 | 0.3085 |
| NPM(%) | -5.06 | -7.27 | -2.96 | 3.84 | 1.29 |
| Revenue | 104.8765 | 128.516 | 124.9009 | 132.7138 | 106.2863 |
| Expenses | 105.3599 | 133.4919 | 124.2695 | 124.3351 | 101.8351 |
| ROE(%) | -53.26 | -93.84 | -37.15 | 51.21 | 13.85 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Kimia Biosciences Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 934.10 | 1.07 | 30.97 | 40.81 | 301.39 | 0.54 |
| Lotus Eye Hospital and Institute Ltd | 76.00 | 2.45 | 215.46 | 148.71 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 22.76 | -0.91 | 0.00 | 308.78 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 896.40 | -1.42 | 0.00 | 140.24 | -601.21 | 0.00 |
Company Info
Laurel Organics Ltd. is a Public limited company, was incorporated in September 1993 in district Gurgaon, Haryana (India). 2017 NCLT approved the Scheme of Arrangement for Amalgamation of Kimia Biosciences Limited (Transferor Company) with Laurel Organics Limited (Transferee Company) 2019 -Company name has changed to Kimia Biosciences Ltd. from Laurel Organics Ltd.. 2024 -Kimia Biosciences Limited has been awarded a contract by a reputed client based in Europe. The Total Value of the Contract is USD 200,000/-
Laurel Organics Ltd. is a Public limited company, was incorporated in September 1993 in district Gurgaon, Haryana (India). 2017 NCLT approved the Scheme of Arrangement for Amalgamation of Kimia Biosciences Limited (Transferor Company) with Laurel Organics Limited (Transferee Company) 2019 -Company name has changed to Kimia Biosciences Ltd. from Laurel Organics Ltd.. 2024 -Kimia Biosciences Limited has been awarded a contract by a reputed client based in Europe. The Total Value of the Contract is USD 200,000/-
Read More
Parent Organisation
Kimia Biosciences Ltd.
Founded
27/09/1993
Managing Director
Mr.Sameer Goel
NSE Symbol
FAQ
The current price of Kimia Biosciences Ltd is
The 52-week high for Kimia Biosciences Ltd is
The market capitalization of Kimia Biosciences Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Kimia Biosciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Kimia Biosciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Kimia Biosciences Ltd shares.
The CEO of Kimia Biosciences Ltd is Mr.Sameer Goel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
